Earnings History Data for Genetron Holdings Limited (GTH) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Genetron Holdings Limited

Genetron Holdings Limited provides precision oncology platform principally in China. It specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company's product and service portfolio cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. Genetron Holdings Limited is based in BEIJING, China.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
02-06-2022	PM	Before the open (Jun 2)	GTH	Genetron Holdings Limited	125.94	-0.30	0.00	-0.19	Genetron Holdings Non-GAAP EPS of -$0.06 misses by $0.04, revenue of $17.4M beats by $0.63M [6/2/2022 7:24 AM]	1.49	0.01 (0.68%)	1.48	0.0 (0.00%)	1.25 - 22.75	181,080	220,000	533
China's Genetron's gene mutation test FusionScan gets CE mark in EU [6/1/2022 6:53 AM] Genetron Holdings Non-GAAP EPS of -$0.06 misses by $0.04, revenue of $17.4M beats by $0.63M [6/2/2022 7:24 AM] Genetron Health Receives CE Mark for FusionScan Plus Kit for Human Multi-Genes [Jun-01-22 06:00AM] Genetron Health Releases 10 New Research Results at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting [Jun-02-22 06:00AM] Genetron Health Reports Unaudited First Quarter 2022 Financial Results [Jun-02-22 07:20AM]
29-03-2022	PM	Before the open (Mar 29)	GTH	Genetron Holdings Limited	258.62	-0.28	0.00	-0.12	Genetron Holdings GAAP EPS of -$0.06 misses by $0.02, revenue of $23.04M beats by $0.66M [3/29/2022 7:30 AM]	2.75	-0.17 (-5.82%)	3.00	0.08 (2.74%)	2.34 - 24.35	469,482	410,000	20,005
Genetron Holdings GAAP EPS of -$0.06 misses by $0.02, revenue of $23.04M beats by $0.66M [3/29/2022 7:30 AM] Genetron Health Announces Unaudited Fourth Quarter and Full Year 2021 Financial Results [Mar-29-22 07:26AM]
30-11-2021	PM	Before the open (Nov 30)	GTH	Genetron Holdings Limited	933.15	-0.22	0.00	-0.08	Genetron Holdings EPS in-line, beats on revenue; updates full year guidance [11/30/2021 5:35 AM]	8.98	-0.62 (-6.46%)	10.40	0.80 (8.33%)	8.73 - 31.54	627,016	180,000	9,195
Genetron Health inks deal with AstraZeneca for MRD tests for solid tumors in China [11/30/2021 1:33 AM] Genetron Holdings EPS in-line, beats on revenue; updates full year guidance [11/30/2021 5:35 AM] Genetron Health Announces Co-Development Agreement with AstraZeneca R&D China for Personalized MRD Tests for Solid Tumors in China [Nov-29-21 10:00PM] Genetron Health Reports Third Quarter 2021 Unaudited Financial Results [Nov-30-21 05:00AM] Why Shares of Genetron Holdings Are Up More than 9.3% on Tuesday [Nov-30-21 12:57PM]
24-08-2021	PM	Before the open (Aug 24)	GTH	Genetron Holdings Limited	1,070	-0.15	0.00	-0.23	Genetron Holdings EPS misses by $0.01, misses on revenue; issues full year guidance [8/24/2021 7:35 AM]	13.25	0.46 (3.60%)	13.50	0.71 (5.55%)	9.03 - 31.54	654,215	240,000	8,718
Genetron enters strategic partnership with Yikon Genomics [8/23/2021 7:37 AM] Genetron Holdings EPS misses by $0.01, misses on revenue; issues full year guidance [8/24/2021 7:35 AM] Genetron Health to Host Calls Following Earnings and Participate in an Upcoming Investor Conference [Aug-23-21 05:00PM] Genetron Health Reaches Strategic Partnership with Yikon Genomics, Expanding S5 Platforms Reach to Reproductive Health Field [Aug-23-21 07:00AM] Genetron Health Reports Second Quarter 2021 Unaudited Financial Results [Aug-24-21 07:23AM] Does This Valuation Of Genetron Holdings Limited (NASDAQ:GTH) Imply Investors Are Overpaying? [Aug-24-21 07:51AM]
24-05-2021	PM	Before the open (May 24)	GTH	Genetron Holdings Limited	1,680	-0.19	0.00	-0.65	Genetron Holdings EPS beats by $0.07, beats on revenue; issues guidance [5/24/2021 6:08 AM]	20.96	-1.58 (-7.01%)	22.90	0.36 (1.60%)	9.03 - 31.54	411,542	300,000	12,421
Genetron Holdings EPS beats by $0.07, beats on revenue; issues guidance [5/24/2021 6:08 AM] Genetron Health Reports First Quarter 2021 Unaudited Financial Results [May-24-21 06:00AM] Genetron Holdings Ltd - ADR to Host Earnings Call [May-24-21 06:45AM]
25-03-2021	PM	Before the open (Mar 25)	GTH	Genetron Holdings Limited	2,030	-0.12	0.00	0.00	Genetron Holdings EPS beats by $0.05, beats on revenue; outlook [3/25/2021 6:57 AM]	19.07	0.25 (1.33%)	18.80	-0.02 (-0.11%)	9.03 - 31.54	197,917	330,000	12,911
Genetron Holdings EPS beats by $0.05, beats on revenue; outlook [3/25/2021 6:57 AM] Genetron Health Releases New Data Results of HCCscreen for Liver Cancer Early Screening in China [Mar-24-21 05:00PM] Genetron Holdings Ltd - ADR to Host Earnings Call [Mar-25-21 06:30AM] Genetron Health Reports Unaudited Fourth Quarter and Full Year 2020 Financial Results, and Provides 2021 Revenue Guidance [Mar-25-21 06:47AM]
09-11-2020	PM	Before the open (Nov 9)	GTH	Genetron Holdings Limited	834.14	-0.08	0.00	0.00	Genetron Holdings reports Q3 results [11/9/2020 6:42 AM]	11.08	1.24 (12.60%)	10.81	0.97 (9.86%)	9.03 - 17.71	305,324	230,568	13,623